Biogen (BIIB) option implied volatility bid after discontinues Alzheimer's trials
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Down)Join SI Premium – FREE
Biogen (NASDAQ: BIIB) March weekly call option implied volatility is at 38, April is at 34; compared to its 52-week range of 21 to 45 after shares sold off 28% after discontinues Alzheimer's drug trials.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) PT Lowered to $270 at Oppenheimer
- Bentley Systems Inc. (BSY) May calls active
- Nordstrom (JWN) 30-day option implied volatility flat
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
